We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Mr. Gene: Launch of the Worldwide First B2B eCommerce Platform for Genetic Engineering
Product News

Mr. Gene: Launch of the Worldwide First B2B eCommerce Platform for Genetic Engineering

Mr. Gene: Launch of the Worldwide First B2B eCommerce Platform for Genetic Engineering
Product News

Mr. Gene: Launch of the Worldwide First B2B eCommerce Platform for Genetic Engineering


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Mr. Gene: Launch of the Worldwide First B2B eCommerce Platform for Genetic Engineering"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GENEART AG has launched 'Mr. Gene' as a second GENEART AG brand. Using the Mr. Gene Internet platform customers can design gene sequences to fit their project plans and then directly order these gene sequences online.

The automated eCommerce platform ensures an attractive price/value ratio. This eCommerce solution provides easy access to synthetic genes especially for scientists from the academic world. The production of synthetic genes now definitely replaces past laborious cloning strategies, and the resulting gene constructs exactly match the customer's project requirements.

From now on however, fully automated Mr. Gene eCommerce platform offers the opportunities to process pure gene synthesis orders online and to optimize genes in a do-it-yourself process at an attractive price. Particularly targeting academic customers, the eCommerce platform favorably positions Mr. Gene in the emerging low-price market for the standardized production of synthetic genes.

The GENEART AG was able to significantly lower the costs of producing synthetic genes through skillful use of automation and miniaturization. Step by step and as a result of these innovations, the production of synthetic genes has replaced the classical genetic engineering methods and has emerged from a niche application to a standard tool in the pharmaceutical and biotechnological industries.

Professor Wagner, CSO of the GENEART AG, elucidates: "The use of synthetic genes in modern biotechnology offers scientists a high level of flexibility. Therefore, universities and public research institutes now also show a strongly growing demand for competitively priced synthetic genes. We are delighted that Mr. Gene will now bring many advantages of using synthetic genes to academic research groups as well."

Christian Ehl, CFO of the GENEART AG, comments: "Mr. Gene as a second brand is our answer to the anticipated strong sales growth in this market segment. Our medium term projections put the Mr. Gene sales at 25 percent of the GENEART sales. The operating margin for Mr. Gene products will be equally attractive thanks to the high level of automation using the eCommerce platform."

Advertisement